Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

首次发布于 2021 年 11 月 12 日

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

计划入组 160 人 · 首次发布于 2025 年 12 月 17 日

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

计划入组 14 人 · 首次发布于 2022 年 5 月 20 日

SKL-14763

thyroid-stimulating hormone receptor antagonists (NIH)

thyroid-stimulating hormone receptor antagonist (graves disease/thyroid eye disease)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Rare Thyroid Therapeutics International AB

Sweden

Egetis Therapeutics to Explore Tiratricol (Emcitate®) for Resistance to Thyroid Hormone Beta (RTHβ)

Autobahn Therapeutics Presents Preclinical Data Supporting Elunetirom's Novel Neuroplasticity Mechanism for Depression Treatment

Eccogene Receives FDA Clearance for Phase 2a MOSAIC Trial Testing Dual-Target MASH Therapy